Shuichi Sakamoto
Chairman at Asahi Kasei Pharma Corp.
Profile
Shuichi Sakamoto is currently the Chairman at Asahi Kasei Pharma Corp.
He previously worked as a Director at Asahi Kasei Corp.
from 2016 to 2019.
Shuichi Sakamoto active positions
Companies | Position | Start |
---|---|---|
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Chairman | 2018-03-31 |
Former positions of Shuichi Sakamoto
Companies | Position | End |
---|---|---|
ASAHI KASEI CORPORATION | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ASAHI KASEI CORPORATION | Process Industries |
Private companies | 1 |
---|---|
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Finance |
- Stock Market
- Insiders
- Shuichi Sakamoto